AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

NEW YORK, Aug. 26, 2024 – AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced a repurchase of 50,296,980 shares of common stock for cancelation. Its positive cash flow continues to come from net profitability to enable the repurchase of more shares in the near future. […]

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″ Fecha: 1 y 2 de octubre 2024 Lugar: Santiago de Chile Organizador: Vostock Capital Sitio Web El 5º Congreso y Exhibición Internacional Minería Chile y América Latina 2024 reúne a más de 200 ejecutivos con poder de decisión de empresas nacionales e internacionales, más de […]

“Mining Chile and Latin America 2024” in Santiago de Chile

“Mining Chile and Latin America 2024” in Santiago de Chile Meet industry leaders and learn the best practices for the mining sector. Date: October 1st and 2nd   2024 Place: Santiago de Chile Organizer: Vostock Capital Website 5th International Congress and Exhibition Mining Chile and Latin America 2024 brings together, during two days,  + 200 decision-makers […]

Biofuels Brazil Forum 2024

Biofuels Brazil Forum 2024 Date: 27-28 November 2024, Sao Paulo, BrazilOrganizer: Vostock CapitalWebsite “Biofuels Brazil International Investment Forum” is the premier platform for biofuel producers, regulatory bodies, government officials, technology pioneers, equipment suppliers, EPC, engineering companies, and investors from Brazil, Latin America, and Europe. It fosters strategic partnerships and innovation in the biofuels sector, advancing […]

Foro Biocombustibles Brasil 2024

Foro Biocombustibles Brasil 2024 Fecha: 27-28 de noviembre de 2024, São Paulo, BrasilOrganizador: Vostock CapitalWebsite El “Foro Internacional de Inversiones en Biocombustibles de Brasil” es la plataforma principal para productores de biocombustibles, organismos reguladores, funcionarios gubernamentales, pioneros tecnológicos, proveedores de equipos, empresas de EPC y de ingeniería, e inversores de Brasil, América Latina y Europa. […]

Fórum de Biocombustíveis Brasil 2024

Fórum de Biocombustíveis Brasil 2024 Data: 27-28 de novembro de 2024, São Paulo, Brasil  Organizador: Vostock Capital  Website O “Fórum Internacional de Investimentos em Biocombustíveis Brasil“ é a principal plataforma para produtores de biocombustíveis, órgãos reguladores, autoridades governamentais, pioneiros em tecnologia, fornecedores de equipamentos, empresas de EPC e engenharia, e investidores do Brasil, América Latina […]

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Pittsburgh, PA, August 22, 2024 – Lipella Pharmaceuticals, Inc. (NASDAQ: LIPO) has launched an Oral Lichen Planus (OLP) Patient Registry. This online platform is designed to enhance research and drive the development of new treatments for OLP, a chronic inflammatory disease affecting the mucous membranes of the mouth. Characterized by symptoms such as burning pain, […]

Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference

Pittsburgh, PA, August 21, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotech company, will highlight clinical data on LP-20, a novel MRI contrast agent designed for diagnosing interstitial cystitis and detecting bladder cancer at the 5th International Consultation on Interstitial Cystitis Japan (ICICJ) in Kyoto, Japan, taking place August 21-23, 2024. LP-20, which […]

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers

Study supports BioStem’s strategic growth initiatives and accelerates product adoption by providing data to healthcare professionals and payers on the benefits of Vendaje POMPANO BEACH, FL, August 21, 2024 – BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that […]

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)

New York, NY. August 21, 2024 – ANEW MEDICAL, INC. (“ANEW” or the “Company”) (NASDAQ: WENA), announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke(“TTS”)regarding Nanoject, a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines. Needle phobia and injection or blood-drawing anxiety are prevalent among adults and children, creating barriers to adhering […]